-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Intraday Session
Share
Listen to the news

Gainers

  • Ekso Bionics Holdings (NASDAQ:EKSO) stock moved upwards by 113.2% to $11.64 during Tuesday's regular session. The market value of their outstanding shares is at $14.3 million.
  • Profusa (NASDAQ:PFSA) shares moved upwards by 70.42% to $0.12. The company's market cap stands at $5.9 million.
  • Jyong Biotech (NASDAQ:MENS) shares rose 33.79% to $3.72. The market value of their outstanding shares is at $211.3 million.
  • Fonar (NASDAQ:FONR) stock increased by 27.66% to $18.71. The market value of their outstanding shares is at $92.3 million.
  • Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 24.73% to $2.32. The company's market cap stands at $1.9 million.
  • Impact BioMedical (AMEX:IBO) stock moved upwards by 17.49% to $0.54. The market value of their outstanding shares is at $5.5 million.

Losers

  • Adlai Nortye (NASDAQ:ANL) stock decreased by 20.8% to $1.43 during Tuesday's regular session. The market value of their outstanding shares is at $66.4 million.
  • Galecto (NASDAQ:GLTO) shares fell 19.41% to $23.86. The company's market cap stands at $47.2 million.
  • PAVmed (NASDAQ:PAVM) stock decreased by 17.8% to $0.23. The company's market cap stands at $7.8 million.
  • BNB Plus (NASDAQ:BNBX) stock declined by 17.28% to $1.82. The company's market cap stands at $9.6 million.
  • Co-Diagnostics (NASDAQ:CODX) shares declined by 15.3% to $0.19. The market value of their outstanding shares is at $13.9 million.
  • Bio Green Med Solution (NASDAQ:BGMSP) shares fell 15.24% to $3.56. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending